Sanders Capital
MRK icon

Sanders Capital’s Merck MRK Stock Holding History

Sanders Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,344
Closed -$110K – 44
2022
Q1 		$110K Hold
1,344
– – ﹤0.01% 43
2021
Q4 		$103K Sell
1,344
-744,278
-100% -$59.3M ﹤0.01% 44
2021
Q3 		$56M Buy
745,622
+8,280
+1% +$630K 0.13% 36
2021
Q2 		$57.3M Sell
737,342
-45,914
-6% -$3.42M 0.13% 34
2021
Q1 		$57.6M Sell
783,256
-2,411
-0.3% -$178K 0.14% 34
2020
Q4 		$61.3M Buy
785,667
+109,726
+16% +$8.39M 0.16% 34
2020
Q3 		$53.5M Sell
675,941
-97,790
-13% -$7.66M 0.18% 35
2020
Q2 		$57.1M Buy
773,731
+37,423
+5% +$2.82M 0.21% 32
2020
Q1 		$54.1M Sell
736,308
-68,539
-9% -$5.39M 0.25% 33
2019
Q4 		$69.8M Buy
804,847
+147,977
+23% +$12.2M 0.25% 36
2019
Q3 		$52.8M Sell
656,870
-2,162,011
-77% -$173M 0.24% 34
2019
Q2 		$226M Buy
2,818,881
+68,120
+2% +$5.22M 1.04% 27
2019
Q1 		$218M Buy
2,750,761
+67,910
+3% +$5.08M 1.05% 28
2018
Q4 		$196M Sell
2,682,851
-732,447
-21% -$51.7M 1.09% 27
2018
Q3 		$231M Sell
3,415,298
-332,933
-9% -$21.2M 1.16% 25
2018
Q2 		$217M Buy
3,748,231
+165,375
+5% +$9.33M 1.16% 26
2018
Q1 		$186M Sell
3,582,856
-175,540
-5% -$9.48M 1.03% 28
2017
Q4 		$202M Sell
3,758,396
-6,434,920
-63% -$357M 1.1% 26
2017
Q3 		$623M Sell
10,193,316
-2,437,804
-19% -$148M 3.76% 11
2017
Q2 		$772M Buy
12,631,120
+480,980
+4% +$29.3M 4.96% 6
2017
Q1 		$752M Buy
12,150,140
+382,809
+3% +$23.2M 4.99% 6
2016
Q4 		$661M Buy
11,767,331
+180,703
+2% +$10.6M 4.7% 8
2016
Q3 		$690M Buy
11,586,628
+78,495
+0.7% +$4.59M 5.45% 5
2016
Q2 		$633M Buy
11,508,133
+23,891
+0.2% +$1.27M 5.25% 5
2016
Q1 		$580M Buy
11,484,242
+1,430,673
+14% +$70.1M 5.01% 5
2015
Q4 		$507M Buy
10,053,569
+361,560
+4% +$18.2M 4.64% 5
2015
Q3 		$457M Buy
9,692,009
+300,043
+3% +$15.9M 4.59% 6
2015
Q2 		$510M Buy
+9,391,966
New +$527M 4.81% 6

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sanders Capital's MRK Position: Q2 2022 in Review

Sanders Capital sold out of Merck (MRK) in Q2 2022, closing a stake of 1,344 shares — an estimated $110K sold.

Sanders Capital first reported a position in MRK in Q2 2015 and held it in 28 quarters. The position peaked at $772M in Q2 2017. 3,015 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Sanders Capital reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Sanders Capital sold 1,344 Merck shares in Q2 2022, an estimated $110K.
  • Sanders Capital first reported a position in Merck in Q2 2015 and held it in 28 quarters.
  • Sanders Capital's Merck position peaked at $772M in Q2 2017.
  • 3,015 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Sanders Capital's 13F filing for Q2 2022, filed 12 Aug 2022.